𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Analysis of human cytomegalovirus glycoprotein N genotypes in Chinese hematopoietic stem cell transplant recipients

✍ Scribed by Chang-sheng Xia; Zheng Zhang

Publisher
Springer Vienna
Year
2010
Tongue
English
Weight
225 KB
Volume
156
Category
Article
ISSN
1432-8798

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinically-based determination of safe D
Clinically-based determination of safe DNAemia cutoff levels for preemptive therapy or human cytomegalovirus infections in solid organ and hematopoietic stem cell transplant recipients
✍ Daniele Lilleri; Fausto Baldanti; Marta Gatti; Francesca Rovida; Luca Dossena; S 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB

## Abstract Transplantation Centers using human cytomegalovirus (HCMV) antigenemia‐based preemptive therapy will need to replace in the near future the antigenemia assay with a more standardized and automatable assay, such as a molecular assay quantifying HCMV DNA in blood (DNAemia). Thus, in view

Ex vivo monitoring of human cytomegalovi
Ex vivo monitoring of human cytomegalovirus-specific CD8+ T-Cell responses using the QuantiFERON®-CMV assay in allogeneic hematopoietic stem cell transplant recipients attending an Irish hospital
✍ T. Fleming; J. Dunne; B. Crowley 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB

## Abstract Reconstitution of human cytomegalovirus (HCMV) T‐cell immunity is crucial in hematopoietic stem cell transplant (HSCT) recipients. The QuantiFERON®‐CMV assay for cellular HCMV‐specific immunity was evaluated in allogeneic HSCT recipients (n = 43) and patients with hematological malignan

Detection of active human cytomegaloviru
Detection of active human cytomegalovirus by the promyelocytic leukemia body assay in cultures of PBMCs from patients undergoing hematopoietic stem cell transplantation
✍ Kiyoko Ogawa-Goto; Tomonori Ueno; Kumi Oshima; Hisashi Yamamoto; Jun Sasaki; Kaz 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 223 KB

## Abstract A novel detection system was established previously for cells infected with the human cytomegalovirus (HCMV) in vitro that utilizes the unique IE1‐dependent nuclear dispersion of promyelocytic leukemia (PML) bodies early in the HCMV replication cycle. This assay system, designated “the

Lack of association between the kinetics
Lack of association between the kinetics of human cytomegalovirus (HCMV) glycoprotein B (gB)-specific and neutralizing serum antibodies and development or recovery from HCMV active infection in patients undergoing allogeneic stem cell transplant
✍ Isabel Muñoz; Antonio Gutiérrez; Concepción Gimeno; Amparo Farga; Juan Alberola; 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 174 KB

The kinetics of the gB-specific and neutralizing antibody responses to human cytomegalovirus (HCMV) were analyzed in 26 allogeneic stem-cell transplant recipients who either did (n = 20) or did not (n = 6) develop asymptomatic HCMV active infection during the study period. Antibody response profiles